Pharmaceutically active compounds in sludge stabilization treatments: Anaerobic and aerobic digestion, wastewater stabilization ponds and composting

Science of the Total Environment

Volumn 503-504, Issue , 2015, Pages 97-104

  Martín, Julia ^a   Santos, Juan Luis ^a   Aparicio, Irene ^a   Alonso, Esteban ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Aerobic treatment; Anaerobic treatment; Pharmaceutically active compounds; Risk assessment; Sewage sludge; Treatment processes

Indexed keywords

AMIDES; ANAEROBIC DIGESTION; ANTIBIOTICS; LAKES; RISK ASSESSMENT; SALICYLIC ACID; SEWAGE LAGOONS; SEWAGE SLUDGE; SLUDGE DISPOSAL; STABILIZATION; STABILIZATION PONDS; WASTEWATER DISPOSAL; WASTEWATER TREATMENT;

AEROBIC TREATMENT; ANAEROBIC TREATMENTS; ANAEROBICALLY DIGESTED SLUDGES; ECOTOXICOLOGICAL RISK ASSESSMENT; PHARMACEUTICALLY ACTIVE COMPOUNDS; PREDICTED ENVIRONMENTAL CONCENTRATIONS; TREATMENT PROCESS; WASTEWATER STABILIZATION PONDS;

SLUDGE DIGESTION;

ATENOLOL; BEZAFIBRATE; CAFFEINE; CARBAMAZEPINE; CIPROFLOXACIN; CLOFIBRIC ACID; DICLOFENAC; DRUG; ESTRADIOL; ESTRIOL; ESTRONE; ETHINYLESTRADIOL; GEMFIBROZIL; IBUPROFEN; KETOPROFEN; NAPROXEN; NORFLOXACIN; OFLOXACIN; PARACETAMOL; PROPRANOLOL; SALICYLIC ACID; SULFAMETHOXAZOLE; TRIMETHOPRIM; SEWAGE; WASTE WATER; WATER POLLUTANT;

ANOXIC CONDITIONS; COMPOSTING; DRUG; OXIC CONDITIONS; SEWAGE TREATMENT; SLUDGE; WASTE DISPOSAL; WASTEWATER;

AEROBIC DIGESTION; AEROBIC METABOLISM; ANAEROBIC DIGESTION; ARTICLE; CHEMICAL ANALYSIS; COMPOSTING; ECOTOXICOLOGY; ENVIRONMENTAL MONITORING; LAGOON; RISK ASSESSMENT; SLUDGE; SLUDGE STABILIZATION; SLUDGE TREATMENT; SOIL; WASTE WATER MANAGEMENT; WASTEWATER STABILIZATION POND; ANAEROBIC GROWTH; ANALYSIS; BIOREMEDIATION; CHEMISTRY; METABOLISM; MICROBIOLOGY; POND; PROCEDURES; SEWAGE; WASTE WATER; WATER POLLUTANT;

AEROBIOSIS; ANAEROBIOSIS; BIODEGRADATION, ENVIRONMENTAL; PHARMACEUTICAL PREPARATIONS; PONDS; RISK ASSESSMENT; SEWAGE; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84909646661     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.05.089     Document Type: Article

References (29)

1. Andersen H.R., Hansen M., Kjølholt J., Stuer-Lauridsen F., Ternes T., Halling-Sørensen B. Assessment of the importance of sorption for steroid estrogens removal during activated sludge treatment. Chemosphere 2005, 61:139-146.
2. Barron L., Havel J., Purcell M., Szpak M., Kelleher B., Paull B. Predicting sorption of pharmaceuticals and personal care products onto soil and digested sludge using artificial neural networks. Analyst 2009, 134:663-670.
3. Beausse J. Selected drugs in solid matrices: a review of environmental determination, occurrence and properties of principal substances. Trends Anal Chem 2004, 23:753-761.
4. Carballa M., Fink G., Omil F., Lema J.M., Ternes T. Determination of the solid-water distribution coefficient (Kd) for pharmaceuticals, estrogens and musk fragrances in digested sludge. Water Res 2008, 42:287-295.
5. Chen Y., Yu G., Cao Q., Zhang H., Lin Q., Hong Y. Occurrence and environmental implications of pharmaceuticals in Chinese municipal sewage sludge. Chemosphere 2013, 93:1765-1772.
6. Clara M., Kreuzinger N., Strenn B., Gans O., Kroiss H. The solid retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 2005, 39:97-106.
7. Clarke B.O., Smith S.R. Review of 'emerging' organic contaminants in biosolids and assessment of international research priorities for the agricultural use of biosolids. Environ Int 2011, 37:226-247.
8. EC (European Commission) Environmental, Economic and Social Impacts of the Use of Sewage Sludge on Land, Final Report, Part III [last accessed date 14 March 2014]. http://ec.europa.eu/environment/waste/sludge/pdf/part_iii_report.pdf.
9. EC-TGD Technical Guidance Document on Risk Assessment, Part II. EUR 20418 EN/2 2003, European Commission, Joint Research Centre.
10. Hernando M.D., Mezcua M., Fernández-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
11. Jelic A., Fatone F., Di Fabio S., Petrovic M., Cecchi F., Barcelo D. Tracing pharmaceuticals in a municipal plant for integrated wastewater and organic solid waste treatment. Sci Total Environ 2012, 433:352-361.
12. Kelessidis A., Stasinakis A.S. Comparative study of the methods used for treatment and final disposal of sewage sludge in European countries. Waste Manag 2012, 32:1186-1195.
13. Li W., Shi Y., Gao L., Liu J., Cai Y. Occurrence, distribution and potential affecting factors of antibiotics in sewage sludge of wastewater treatment plants in China. Sci Total Environ 2013, 445-446:306-313.
14. Lindberg R.H., Olofsson U., Rendahl P., Johansson M.I., Tysklind M., Andersson B.A.V. Behavior of fluoroquinolones and trimethoprim during mechanical, chemical, and active sludge treatment of sewage water and digestion of sludge. Environ Sci Technol 2006, 40:1042-1048.
15. Martín J., Santos J.L., Aparicio I., Alonso E. Multi-residue method for the analysis of pharmaceutical compounds in sewage sludge, compost and sediments by sonication-assisted extraction and LC determination. J Sep Sci 2010, 33:1760-1766.
16. Martín J., Camacho-Muñoz D., Santos J.L., Aparicio I., Alonso E. Distribution and temporal evolution of pharmaceutically active compounds alongside sewage sludge treatment. Risk assessment of sludge application onto soils. J Environ Manag 2012, 102:18-25.
17. McClellan K., Halden R.U. Pharmaceuticals and personal care products in archived U.S. Biosolids from the 2001 EPA National Sewage Sludge Survey. Water Res 2010, 44:658-668.
18. Mikami E., Goto T., Ohno T., Matsumoto H., Nishida M. Simultaneous analysis of dehydroacetic acid, benzoic acid, sorbic acid and salicylic acid in cosmetic products by solid-phase extraction and high-performance liquid chromatography. J Pharm Biomed Anal 2002, 28:261-267.
19. Oulton R.L., Kohn T., Cwiertny D.M. Pharmaceuticals and personal care products in effluent matrices: a survey of transformation and removal during wastewater treatment and implications for wastewater management. J Environ Monit 2010, 12:1956-1978.
20. Paterakis N., Chiu T.Y., Koh Y.K.K., Lester J.N., McAdam E.J., Scrimshaw M.D., et al. The effectiveness of anaerobic digestion in removing estrogens and nonylphenol ethoxylates. J Hazard Mater 2012, 199-200:88-95.
21. Radjenović J., Petrovic M., Barceló D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 2009, 43:831-841.
22. Reif R., Santos A., Judd S.J., Lema J.M., Omil F. Occurrence and fate of pharmaceutical and personal care products in a sewage treatment works. J Environ Monit 2012, 13:137-144.
23. Reyes-Contreras C., Matamoros V., Ruiz I., Soto M., Bayona J.M. Evaluation of PPCPs removal in a combined anaerobic digester-constructed wetland pilot plant treating urban wastewater. Chemosphere 2011, 84:1200-1207.
24. Sabourin L., Duenk P., Bonte-Gelok S., Payne M., Lapen D.R., Topp E. Uptake of pharmaceuticals, hormones and parabens into vegetables grown in soil fertilized with municipal biosolids. Sci Total Environ 2012, 431:233-236.
25. Stasinakis A.S. Review on the fate of emerging contaminants during sludge anaerobic digestion. Bioresour Technol 2012, 121:432-440.
26. Suárez S., Reif R., Lema J.M., Omil F. Mass balance of pharmaceutical and personal care products in a pilot-scale single-sludge system: influence of T, SRT and recirculation ratio. Chemosphere 2012, 89:164-171.
27. Urase T., Kikuta T. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Res 2005, 39:1289-1300.
28. USEPA POTW Sludge Sampling and Analysis Guidance Document. EPA 833-B-89-100 Available from, [11th November 2009]. http://www.epa.gov/npdes/pubs/owm012.pdf.
29. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci Total Environ 2012, 429:123-155.